PuSH - Publication Server of Helmholtz Zentrum München: Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter study.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Buchner, J.A.* ; Kofler, F. ; Etzel, L.* ; Mayinger, M.* ; Christ, S.M.* ; Brunner, T.B.* ; Wittig, A.* ; Menze, B.* ; Zimmer, C.* ; Meyer, B.* ; Guckenberger, M.* ; Andratschke, N.* ; El Shafie, R.A.* ; Debus, J.* ; Rogers, S.* ; Riesterer, O.* ; Schulze, K.* ; Feldmann, H.J.* ; Blanck, O.* ; Zamboglou, C.* ; Ferentinos, K.* ; Wolff, R.* ; Eitz, K.A. ; Combs, S.E. ; Bernhardt, D.* ; Wiestler, B.* ; Peeken, J.C.

Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter study.

Radiother. Oncol. 178:109425 (2022)

DOI

PMC

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

BACKGROUND: Stereotactic radiotherapy is a standard treatment option for patients with brain metastases. The planning target volume is based on gross tumor volume (GTV) segmentation. The aim of this work is to develop and validate a neural network for automatic GTV segmentation to accelerate clinical daily routine practice and minimize interobserver variability. METHODS: We analyzed MRIs (T1-weighted sequence ± contrast-enhancement, T2-weighted sequence, and FLAIR sequence) from 348 patients with at least one brain metastasis from different cancer primaries treated in six centers. To generate reference segmentations, all GTVs and the FLAIR hyperintense edematous regions were segmented manually. A 3D-U-Net was trained on a cohort of 260 patients from two centers to segment the GTV and the surrounding FLAIR hyperintense region. During training varying degrees of data augmentation were applied. Model validation was performed using an independent international multicenter test cohort (n=88) including four centers. RESULTS: Our proposed U-Net reached a mean overall Dice similarity coefficient (DSC) of 0.92 ± 0.08 and a mean individual metastasis-wise DSC of 0.89 ± 0.11 in the external test cohort for GTV segmentation. Data augmentation improved the segmentation performance significantly. Detection of brain metastases was effective with a mean F1-Score of 0.93 ± 0.16. The model performance was stable independent of the center (p = 0.3). There was no correlation between metastasis volume and DSC (Pearson correlation coefficient 0.07). CONCLUSION: Reliable automated segmentation of brain metastases with neural networks is possible and may support radiotherapy planning by providing more objective GTV definitions.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Altmetric

6.901

0.000